Home › Funds › Dauntless Investment Group, LLC › KZIA

Dauntless Investment Group, LLC position in KZIA

KAZIA THERAPEUTICS LTD · Health Care

Dauntless Investment Group, LLC reported holding 354,208 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 3.92% of its reported portfolio and ranking #6 among its reported holdings. Dauntless Investment Group, LLC has disclosed KZIA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)354.21K sh
Reported value held$4.99M
Portfolio Weight3.92%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Dauntless Investment Group, LLC's KZIA position evolved

Dauntless Investment Group, LLC first disclosed a stake in KZIA in Q2 2025 at 115,769 shares (US$726K). The position peaked in Q2 2026 at 354,208 shares, worth US$5.0M. Across 5 filings, Dauntless Investment Group, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 354,208 shares valued at US$5.0M — an increase of 274,376 shares quarter over quarter.. Notable position changes include a 100% trim in Q4 2025 (shares rose 8% over the following quarter), a 7983100% increase in Q1 2026 (shares rose 89% over the following quarter), a 344% increase in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 115.77K $725.87K New
Q3 2025 118.14K $851.78K Add
Q4 2025 1 $7 Reduce
Q1 2026 79.83K $593.95K Add
Q2 2026 354.21K $4.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KZIA and 13F data

KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 41 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Bleichroeder LP (US$5.6M), Ikarian Capital, LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KZIA

All KZIA fund holders →

FAQ

How long has Dauntless Investment Group, LLC held KZIA?

Dauntless Investment Group, LLC has disclosed KZIA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Dauntless Investment Group, LLC's current position in KZIA?

As of Q2 2026, Dauntless Investment Group, LLC holds 354.21K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $4.99M, representing 3.92% of its reported portfolio and ranking #6.

Has Dauntless Investment Group, LLC been buying or selling KZIA?

In the latest 13F filing (Q2 2026), Dauntless Investment Group, LLC increased its position in KZIA. The position peaked in Q2 2026 at 354.21K shares.

Which other funds hold KZIA?

Other major institutional holders of KZIA include Boxer Capital Management, LLC, Bleichroeder LP, Ikarian Capital, LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.